Your browser doesn't support javascript.
loading
Azaindoles as Zinc-Binding Small-Molecule Inhibitors of the JAMM Protease CSN5.
Altmann, Eva; Erbel, Paul; Renatus, Martin; Schaefer, Michael; Schlierf, Anita; Druet, Adelaide; Kieffer, Laurence; Sorge, Mickael; Pfister, Keith; Hassiepen, Ulrich; Jones, Matthew; Ruedisser, Simon; Ostermeier, Daniela; Martoglio, Bruno; Jefferson, Anne B; Quancard, Jean.
Afiliação
  • Altmann E; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Erbel P; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Renatus M; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Schaefer M; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Schlierf A; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Druet A; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Kieffer L; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Sorge M; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Pfister K; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Hassiepen U; Novartis Institutes for BioMedical Research, 4560 Horton Street, Emeryville, CA, 94608-2916, USA.
  • Jones M; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Ruedisser S; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Ostermeier D; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Martoglio B; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Jefferson AB; Novartis Institutes for BioMedical Research, Novartis Campus, 4002, Basel, Switzerland.
  • Quancard J; Pharma Research and Early Development, Roche Innovation Center Basel, 4070, Basel, Switzerland.
Angew Chem Int Ed Engl ; 56(5): 1294-1297, 2017 01 24.
Article em En | MEDLINE | ID: mdl-27981705
ABSTRACT
CSN5 is the zinc metalloprotease subunit of the COP9 signalosome (CSN), which is an important regulator of cullin-RING E3 ubiquitin ligases (CRLs). CSN5 is responsible for the cleavage of NEDD8 from CRLs, and blocking deconjugation of NEDD8 traps the CRLs in a hyperactive state, thereby leading to auto-ubiquitination and ultimately degradation of the substrate recognition subunits. Herein, we describe the discovery of azaindoles as a new class of CSN5 inhibitors, which interact with the active-site zinc ion of CSN5 through an unprecedented binding mode. The best compounds inhibited CSN5 with nanomolar potency, led to degradation of the substrate recognition subunit Skp2 in cells, and reduced the viability of HCT116 cells.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Zinco / Complexo do Signalossomo COP9 / Indóis Limite: Humans Idioma: En Revista: Angew Chem Int Ed Engl Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Zinco / Complexo do Signalossomo COP9 / Indóis Limite: Humans Idioma: En Revista: Angew Chem Int Ed Engl Ano de publicação: 2017 Tipo de documento: Article